A detailed history of Howland Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Howland Capital Management LLC holds 2,890 shares of AMGN stock, worth $759,058. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,890
Previous 2,103 37.42%
Holding current value
$759,058
Previous $657,000 41.7%
% of portfolio
0.04%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $243,482 - $265,518
787 Added 37.42%
2,890 $931,000
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $788 - $957
3 Added 0.14%
2,103 $657,000
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $33,608 - $40,570
-125 Reduced 5.62%
2,100 $597,000
Q4 2023

Jan 23, 2024

BUY
$255.7 - $288.46 $62,646 - $70,672
245 Added 12.37%
2,225 $640,000
Q3 2023

Oct 17, 2023

SELL
$218.65 - $271.46 $91,833 - $114,013
-420 Reduced 17.5%
1,980 $532,000
Q2 2023

Jul 28, 2023

BUY
$214.27 - $253.37 $21,427 - $25,337
100 Added 4.35%
2,400 $532,000
Q1 2023

May 05, 2023

BUY
$225.79 - $275.2 $27,094 - $33,024
120 Added 5.5%
2,300 $556,000
Q3 2022

Oct 17, 2022

SELL
$224.46 - $253.15 $1,346 - $1,518
-6 Reduced 0.27%
2,180 $491,000
Q2 2022

Jul 22, 2022

BUY
$230.71 - $256.74 $125,275 - $139,409
543 Added 33.05%
2,186 $532,000
Q1 2022

Apr 27, 2022

SELL
$219.27 - $242.57 $5,701 - $6,306
-26 Reduced 1.56%
1,643 $397,000
Q4 2021

Jan 26, 2022

SELL
$198.88 - $227.6 $12,529 - $14,338
-63 Reduced 3.64%
1,669 $375,000
Q3 2021

Oct 25, 2021

SELL
$212.27 - $248.7 $54,128 - $63,418
-255 Reduced 12.83%
1,732 $368,000
Q1 2021

Apr 28, 2021

SELL
$221.91 - $258.6 $33,286 - $38,790
-150 Reduced 7.02%
1,987 $494,000
Q4 2020

Jan 26, 2021

SELL
$216.38 - $257.67 $9,520 - $11,337
-44 Reduced 2.02%
2,137 $491,000
Q2 2020

Jul 15, 2020

SELL
$197.81 - $242.74 $10,681 - $13,107
-54 Reduced 2.42%
2,181 $514,000
Q1 2020

Apr 13, 2020

SELL
$182.24 - $241.7 $94,947 - $125,925
-521 Reduced 18.9%
2,235 $453,000
Q4 2019

Jan 23, 2020

SELL
$189.21 - $243.2 $59,222 - $76,121
-313 Reduced 10.2%
2,756 $664,000
Q3 2019

Oct 22, 2019

BUY
$174.11 - $208.62 $200,922 - $240,747
1,154 Added 60.26%
3,069 $594,000
Q2 2019

Jul 17, 2019

SELL
$166.7 - $195.41 $8,335 - $9,770
-50 Reduced 2.54%
1,915 $353,000
Q1 2019

Apr 22, 2019

SELL
$180.87 - $203.88 $3,798 - $4,281
-21 Reduced 1.06%
1,965 $373,000
Q4 2018

Jan 23, 2019

SELL
$178.4 - $208.25 $4,995 - $5,831
-28 Reduced 1.39%
1,986 $387,000
Q3 2018

Oct 25, 2018

SELL
$185.29 - $208.89 $555 - $626
-3 Reduced 0.15%
2,014 $417,000
Q1 2018

May 02, 2018

BUY
$169.43 - $198.0 $5,252 - $6,138
31 Added 1.56%
2,017 $344,000
Q3 2017

Oct 30, 2017

BUY
$167.29 - $191.0 $332,237 - $379,326
1,986
1,986 $370,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Howland Capital Management LLC Portfolio

Follow Howland Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.